Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 30 | Mehta RajatEVP, GBL Commercial Operations |  BIOBIO.BBIO-RAD LABORATORIES, INC.Tax withholding | F | $90K 233 sh | Sep 9, 2026 |
| 30 | Phillips DominicSEE REMARKS | IOTSamsara Inc. Open-market sale · 10b5-1 plan | SELL | $518K 11.7K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 56 | Stamler David AllenDirector, Chief Executive Officer |  ATHEALTERITY THERAPEUTICS LTDOpen-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 56 | Cheng LawrenceDirector |  GMEGameStop Corp.Open-market purchase | BUY | $1.03M 55.0K sh | Sep 8, 2026 traded Sep 8, 2026 |
| 56 | Marks Peter AshleyDirector | ATHEALTERITY THERAPEUTICS LTD Open-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 52 | Marks Peter AshleyDirector | ATHEALTERITY THERAPEUTICS LTD Open-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 51 | Speth RalfDirector |  SHMDSCHMID Group N.V.Open-market purchase | BUY | $114K 35.0K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 51 | Roeder Clinton WilliamChief Financial Officer |  TISITEAM INCOpen-market purchase | BUY | $221K 8,000 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 48 | Meyer-Gloeckner Birger JohannesDirector |  ZIMZIM Integrated Shipping Services Ltd.Open-market sale | SELL | $44K 1,531 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 46 | ADAR1 Capital Management, LLC10% Owner |  TENXTENAX THERAPEUTICS, INC.Open-market purchase | BUY | $1.60M 900.0K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 46 | Wambeke David J.Chief Business Officer |  NMTCNEUROONE MEDICAL TECHNOLOGIES CorpOpen-market purchase | BUY | $67K 33.3K sh | Sep 8, 2026 traded Aug 27, 2026 |
| 43 | Speth RalfDirector | SHMDSCHMID Group N.V. Open-market purchase | BUY | $101K 33.0K sh | Sep 8, 2026 traded Sep 2, 2026 |
| 42 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Open-market purchase | BUY | $4.11M 54.3K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 41 | Bradford Tonya WilliamsDirector |  LOBLive Oak Bancshares, Inc.Open-market sale | SELL | $64K 1,600 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 38 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Open-market purchase | BUY | $1.20M 15.7K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Courtney Mark RVice President of Supply Chain |  KTCCKEY TRONIC CORPOpen-market sale | SELL | $1,324 566 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Musa FernandoDirector |  PCTPureCycle Technologies, Inc.Open-market purchase | BUY | $99K 15.5K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Agress Adam LEVP Business Development | KTCCKEY TRONIC CORP Open-market sale | SELL | $2,602 1,112 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Voorhees Anthony GeneEVP-Admin, CFO, Treasurer | KTCCKEY TRONIC CORP Open-market sale | SELL | $3,283 1,403 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 34 | Lantheus Alpha Therapy, LLC10% Owner |  CATXPerspective Therapeutics, Inc.Open-market sale | SELL | $251K 80.8K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 33 | Gehring Rob L.CEO, Americas |  MNSTMonster Beverage CorpTax withholding | F | $386K 8,760 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 33 | Grayson Blake JeffreyChief Financial Officer |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $2.10M 30.0K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | Sever MichalCMO |  NYAXNayax Ltd.Open-market sale | SELL | $1,779 34 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | McLaughlin Matthew F.Director, Chief Executive Officer |  SCORCOMSCORE, INC.Open-market purchase | BUY | $84K 16.6K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | Berho Carranza DiegoChief Portfolio Officer |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $22K 6,219 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 31 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Open-market sale | SELL | $249K 5,666 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 31 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $255K 9,705 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 31 | Speth RalfDirector | SHMDSCHMID Group N.V. Grant or award | A | $96K 16.3K sh | Sep 8, 2026 traded May 23, 2026 |
| 31 | Prosor MayaChief Business Officer |  LMNDLemonade, Inc.Open-market sale | SELL | $57K 1,040 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 56 | De Angoitia AlfonsoDirector |  LILALiberty Latin America Ltd.Open-market purchase | BUY | $3.06M 145.5K sh | Sep 4, 2026 traded Aug 31, 2026 |
| 52 | Lacerte Rene A.Director, CEO |  BILLBILL Holdings, Inc.Open-market sale | SELL | $4.90M 100.9K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 50 | Spetzler David BaxleyPresident |  CAICaris Life Sciences, Inc.Open-market sale | SELL | $9.73M 393.1K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 50 | Steiner Jason RobertSEE REMARKS |  PFLEXPIMCO Flexible Credit Income FundOpen-market purchase | BUY | $1.01M 148.8K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 48 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $1.31M 27.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 48 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $1.94M 40.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 46 | De Angoitia AlfonsoDirector | LILALiberty Latin America Ltd. Open-market purchase | BUY | $6.56M 313.1K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 46 | Spetzler David BaxleyPresident | CAICaris Life Sciences, Inc. Open-market sale | SELL | $2.15M 84.9K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 46 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $260K 9,852 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 46 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $293K 11.3K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 44 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $1.18M 24.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K